Kymera Therapeutics COO sells $1.9 million in shares By Investing.com

robot
Abstract generation in progress

Kymera Therapeutics COO Jeremy G. Chadwick sold 22,240 shares of common stock for approximately $1.9 million on March 31 and April 1, 2026. This sale, executed under a Rule 10b5-1 trading plan, followed a 237% stock rally and occurred while the stock was deemed overvalued by InvestingPro. Chadwick also exercised options for the same number of shares, increasing his direct ownership to 61,202 shares after these transactions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin